Monday, March 3rd, 2008
Biothera's Imprime PGG™ increased the effectiveness of Avastin(R) (bevacizumab), a monoclonal antibody approved for the treatment of metastatic colorectal, breast and non-small cell lung cancer, according to a new preclinical study published in the current issue of Clinical Cancer Research.
Researchers in the Tumor Immunobiology Program of the James Graham Brown ...
Posted in Colorectal Cancer | No Comments »
Thursday, February 28th, 2008
Researchers from Boston University School of Medicine and Harvard Medical School have found that diltiazem, a drug used in the treatment of high blood pressure, reduces cocaine cravings in a rat model. These findings will appear in the March issue of the leading medical journal Nature Neuroscience.
Previous work showed that ...
Posted in Alcohol / Addiction | No Comments »
Thursday, February 28th, 2008
"We have identified a key connection of signaling pathways in the cascade of events leading to sepsis. This defines a crucial point where the immune system spirals out of control to cause severe sepsis and where there is an opportunity for therapeutic intervention," says Scripps Research Professor Wolfram Ruf, who ...
Posted in Infectious Diseases | No Comments »
Tuesday, February 26th, 2008
New Mexico's Department of Health recently added three antiretroviral drugs to its AIDS Drug Assistance Program, the AP/Las Cruces Sun-News reports. The health department now provides 77 medications to 426 people through its ADAP, which has been in operation for at least 12 years, according to health officials. All of ...
Posted in HIV / AIDS | No Comments »
Monday, February 25th, 2008
Sirtris Pharmaceuticals (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced that it will collaborate with the National Cancer Institute to test the anti-cancer impact of Sirtris' SIRT1 enzyme activators in numerous models of cancer.
"By providing the resources for this ...
Posted in Cancer / Oncology | No Comments »
Saturday, February 23rd, 2008
Arbios Systems, Inc. (OTC Bulletin Board: ABOS) announced that the Company has received conditional approval from the U.S. Food and Drug Administration ("FDA") of an Investigational Device Exemption ("IDE") to begin the pivotal clinical trial for SEPET(TM), Arbios' extracorporeal (outside the body) artificial liver assist device for blood purification of ...
Posted in Liver Disease / Hepatitis | No Comments »
Saturday, February 23rd, 2008
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products, announced initial clinical results of stand-alone ablation procedures and an overall expansion into the stand-alone market, using the ATS CryoMaze(TM) product line. This line of surgical products, indicated for the treatment of cardiac arrhythmias, is designed to ...
Posted in Cervical Cancer | No Comments »
Saturday, February 23rd, 2008
An article published on bmj.com claims that drug companies are still directly sponsoring the education of thousands of general practitioners. The Australian investigation is reported while the world is calling for an end to direct sponsorship by drug companies.
In Australia, it is common for drug company sponsors to recommend speakers ...
Posted in Medical Students | No Comments »
Saturday, February 23rd, 2008
CMS has ordered California-based health insurer Health Net to stop marketing and enrollment for its "Health Net Orange" Medicare prescription drug plans, according to a notice on a government Web site, Florida Health News reports. The freeze was enacted because the company failed to process enrollment applications on time and ...
Posted in Health Insurance | No Comments »
